Felicia L Lane

Felicia L Lane, MD is a Professor in the Department of Obstetrics and Gynecology at the University of California, Irvine School of Medicine, serving as Vice Chair for Academic Affairs. Her research focuses on pelvic organ prolapse (POP) mechanisms, including the role of elastin metabolism proteins like LOXL1 and Fibulin-5 in vaginal secretions. She also investigates neuromodulation therapies for urinary incontinence, contributing to device development and clinical trials for overactive bladder treatment. Dr. Lane’s work bridges basic science and clinical applications, emphasizing translational research in gynecology and urology. Her studies include comparative trials on surgical graft materials and implantable medical devices, demonstrating expertise in both molecular biology and surgical outcomes. Her leadership in academic affairs highlights institutional contributions to medical education and research governance.

Research interests span pelvic floor disorders, with a focus on biomarker discovery and innovative therapeutic approaches. Her recent studies include non-inferiority trials comparing biological grafts to native tissue repair and evaluating rechargeable neuromodulation systems for long-term efficacy. Clinical trials involve collaborations to assess novel therapies for POP and urgency incontinence. She has published on complications of botulinum toxin use, underscoring attention to patient safety in interventional treatments.

Dr. Lane’s articles reflect multidisciplinary collaboration, combining molecular analysis with clinical outcomes. Recent work emphasizes patient-centric neuromodulation solutions, demonstrating high safety and symptom improvement rates. Her contributions to the field are recognized through academic leadership roles and peer-reviewed publications addressing both foundational and applied research challenges in urogynecology.